Special Issue "Personalized Medicine for Neuroimmunology and Epigenetics in Depressive Disorders"
Deadline for manuscript submissions: closed (5 January 2021).
Interests: clinical psychiatry; neuroimmunology; epigenetics; depression
Interests: immunopsychiatry; nutritional psychiatry
Depressive disorders are one of the most common mental disorders worldwide, with more than 264 million people affected. They are a leading cause of disability. Despite their high prevalence, the etiopathogenesis of depressive disorders is not yet fully understood. The aim of recent studies in the field of psychiatry is to seek consistent theory that would exhaustively explain the aetiology of depression. Neuroimmunology, epigenetics, and their correlations seem to play an important role in this matter.
We would like to invite experts from all over the world to participate in our common project, a Special Issue of the Journal of Personalized Medicine, titled Personalized Medicine for Neuroimmunology and Epigenetics in Depressive Disorders, in which we would like to focus on the biological background of depressive disorders. Nowadays, when one third of the patients suffer from treatment resistant depression, seeking for new therapeutic targets is especially important. Since depression also has a significant impact on socioeconomics, scientists are also seeking methods of its primary prevention.
Original research papers, brief scientific reports, as well as review papers, regarding the given topic, will be considered for publication in this Special Issue ‘’Personalized Medicine for Neuroimmunology and Epigenetics in Depressive Disorders’’.
Prof. Dr. Piotr Galecki
Prof. Dr. Kuan-Pin Su
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Major depressive disorder